CHARLES RIVER LABORATORIES INTERNATIONAL INC
For the period ended Dec 30, 2023. Filed Feb 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 14, 2024
CRL$345.80-2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income for fiscal yearsand
| Fiscal Year | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net income | $480,370 | $492,608 | $398,837 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | 70,651 | (129,091) | (29,493) |
| Pension and other post-retirement benefit plans (Note 14): | |||
| Prior service cost and (losses) gains arising during the period | (5,376) | 24,471 | (1,193) |
| Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans | 736 | 3,337 | 1,678 |
| Unrealized gains (losses) on hedging instruments | 2,490 | (1,523) | — |
| Other comprehensive income (loss), before income taxes | 68,501 | (102,806) | (29,008) |
| Less: Income tax (benefit) expense related to items of other comprehensive income (Note 12) | 4,071 | (1,905) | (3,965) |
| Comprehensive income, net of income taxes | 544,800 | 391,707 | 373,794 |
| Less: Comprehensive income related to noncontrolling interests, net of income taxes | 4,546 | 2,798 | 8,678 |
| Comprehensive income attributable to common shareholders, net of income taxes | $540,254 | $388,909 | $365,116 |
| See Notes to Consolidated Financial Statements. | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.